Fehlmann Elisa, Tapia José L, Fernández Rocío, Bancalari Aldo, Fabres Jorge, D'Apremont Ivonne, García-Zattera María J, Grandi Carlos, Ceriani Cernadas José M
Hospital Español, Mendoza, Argentina.
Arch Argent Pediatr. 2010 Oct;108(5):393-400. doi: 10.1590/S0325-00752010000500004.
To analyze the incidence, risk factors, major morbidity, mortality and resource employment in very low birth weight infants (< 1500 g) with respiratory distress syndrome (RDS).
Descriptive study using prospectively obtained on-line information from a data base of 20 units belonging to the South American Neocosur Network. A total of 5991 VLBW infants were registered during years 2002-2007.
The mean gestacional age was 29.1 weeks (95% CI 29.06-29.21) and the mean of birth weight was 1100.5 g (95% CI 1093.79-1107.37). The global incidence of RDS was 74% (95% CI 73-75). Antenatal steroids were administered to 73% of this population. The main risk factor was lower gestational age (p< 0.001); where as prenatal steroids (OR: 0.59; 95% CI 0.49-0.72), female gender (OR: 0.77; 95% CI 0.67-0.89) and premature rupture of membranes (OR: 0.81; 95% CI 0.68-0.96) were protective factors. Antenatal steroids was also associated with a decrease in mortality in those infants that presented with RDS (OR: 0.40; 95% CI 0.34-0.47). Use of resources was higher in the group with RDS, with a greater use of surfactant (74.3% vs. 7.3%, p< 0.001), mechanical ventilation (82.1% vs. 23.8%, p< 0.001), and more days of oxygen (median of 8 vs. 1 day, p< 0.001) and hospitalization (median of 61 vs. 45 days, p< 0.001). RDS was associated to an increase risk in the incidence of ROP, PDA, late onset sepsis, severe IVH and oxygen requirement at 36 weeks of corrected gestational age.
RDS had a high incidence in very low birth weight infants, despite the frequent use of antenatal steroids. VLBW Infants with RDS had a higher mortality and an increase risk of relevant morbidity. RDS also increased use of resources.
分析出生体重极低(<1500g)的呼吸窘迫综合征(RDS)婴儿的发病率、危险因素、主要发病情况、死亡率及资源利用情况。
采用描述性研究,前瞻性地从南美Neocosur网络20个单位的数据库中获取在线信息。2002年至2007年期间共登记了5991例极低出生体重婴儿。
平均胎龄为29.1周(95%可信区间29.06 - 29.21),平均出生体重为1100.5g(95%可信区间1093.79 - 1107.37)。RDS的总体发病率为74%(95%可信区间73 - 75)。该人群中73%接受了产前类固醇治疗。主要危险因素是胎龄较小(p<0.001);而产前类固醇(比值比:0.59;95%可信区间0.49 - 0.72)、女性性别(比值比:0.77;95%可信区间0.67 - 0.89)和胎膜早破(比值比:0.81;95%可信区间0.68 - 0.96)是保护因素。产前类固醇还与患有RDS的婴儿死亡率降低相关(比值比:0.40;95%可信区间0.34 - 0.47)。RDS组的资源使用更高,使用表面活性剂的比例更高(74.3%对7.3%,p<0.001)、机械通气比例更高(82.1%对23.8%,p<0.001),吸氧天数更多(中位数8天对1天,p<0.001)以及住院天数更多(中位数61天对45天,p<0.001)。RDS与矫正胎龄36周时视网膜病变、动脉导管未闭、晚发性败血症、重度脑室内出血和吸氧需求的发病率增加相关。
尽管产前类固醇使用频繁,但极低出生体重婴儿中RDS的发病率仍很高。患有RDS的极低出生体重婴儿死亡率更高,相关发病风险增加。RDS还增加了资源的使用。